Literature DB >> 8556477

Purification of Borrelia burgdorferi outer surface protein A (OspA) and analysis of antibody binding domains.

W Jiang1, P D Gorevic, R J Dattwyler, J J Dunn, B J Luft.   

Abstract

The major outer surface protein, OspA, of Borrelia burgdorferi is a lipoprotein which is a particular interest because of its potential as a vaccine candidate. However, serotypic and genetic analysis of OspA from both European and North American strains have demonstrated antigenic and structural heterogeneities. We purified OspA to homogeneity by exploiting its resistance to trypsin digestion. By treating spirochetes with trypsin and then using Triton X-114 extraction and ion-exchange chromatography, we obtained a yield of 2 mg of pure OspA protein per liter of culture. INtrinsic labeling with [14C]palmitic acid confirmed that OspA was lipidated, and partial digestion established lipidation at the amino-terminal end of the molecule. The reactivity of five anti-OspA murine monoclonal antibodies to nine different isolates of B. burgdorferi was ascertained by Western blot (immunoblot) analysis. Purified OspA was fragmented by enzymatic or chemical cleavage, and the monoclonal antibodies were able to define four distinct immunogenic domains. Further resolution of the epitope specificity to determine humoral and cellular immune responses to OspA has implications for vaccine development and for the utility of this protein as a reagent in diagnostic testing for Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556477      PMCID: PMC368276          DOI: 10.1128/cdli.1.4.406-412.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  32 in total

1.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.

Authors:  A G Barbour; S L Tessier; W J Todd
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

4.  Variation in a major surface protein of Lyme disease spirochetes.

Authors:  A G Barbour; S L Tessier; S F Hayes
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

6.  Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis.

Authors:  J L Coleman; J L Benach
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

7.  A Borrelia-specific monoclonal antibody binds to a flagellar epitope.

Authors:  A G Barbour; S F Hayes; R A Heiland; M E Schrumpf; S L Tessier
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

8.  Selective chemical cleavage of tryptophanyl peptide bonds by oxidative chlorination with N-chlorosuccinimide.

Authors:  Y Shechter; A Patchornik; Y Burstein
Journal:  Biochemistry       Date:  1976-11-16       Impact factor: 3.162

9.  Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.

Authors:  M M Simon; U E Schaible; M D Kramer; C Eckerskorn; C Museteanu; H K Müller-Hermelink; R Wallich
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

10.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  6 in total

1.  Determination of Borrelia surface lipoprotein anchor topology by surface proteolysis.

Authors:  Shiyong Chen; Ozan S Kumru; Wolfram R Zückert
Journal:  J Bacteriol       Date:  2011-09-09       Impact factor: 3.490

2.  Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab.

Authors:  H Li; J J Dunn; B J Luft; C L Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment.

Authors:  Abhijeet Nayak; Wolfgang Schüler; Stefan Seidel; Ivan Gomez; Andreas Meinke; Pär Comstedt; Urban Lundberg
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

4.  Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes.

Authors:  Jasmin Federizon; Amber Frye; Wei-Chiao Huang; Thomas M Hart; Xuedan He; Christopher Beltran; Ashley L Marcinkiewicz; Iain L Mainprize; Melanie K B Wills; Yi-Pin Lin; Jonathan F Lovell
Journal:  Vaccine       Date:  2019-11-11       Impact factor: 3.641

5.  Agglutination of Borreliella burgdorferi by Transmission-Blocking OspA Monoclonal Antibodies and Monovalent Fab Fragments.

Authors:  Amber M Frye; Monir Ejemel; Lisa Cavacini; Yang Wang; Michael J Rudolph; Renjie Song; Nicholas J Mantis
Journal:  Infect Immun       Date:  2022-08-24       Impact factor: 3.609

6.  Design of a broadly reactive Lyme disease vaccine.

Authors:  Heather D Kamp; Kurt A Swanson; Ronnie R Wei; Pradeep K Dhal; Ram Dharanipragada; Aurelie Kern; Bijaya Sharma; Radek Sima; Ondrej Hajdusek; Linden T Hu; Chih-Jen Wei; Gary J Nabel
Journal:  NPJ Vaccines       Date:  2020-05-01       Impact factor: 7.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.